Jaka jest cena za General Biologicals Corporation (4117)

Cena za General Biologicals Corporation (4117) wynosi $0.31640033

Jaka jest kapitalizacja rynkowa dla General Biologicals Corporation (4117)

Kapitalizacja rynkowa dla General Biologicals Corporation (4117) wynosi $22.25M

General Biologicals Corporation (4117) Marża Operacyjna

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
STERIS plc STE.US	18.91%	-	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0.00%	-	CN
Ypsomed Holding AG YPSN.SW	0.00%	-	CH
Medacta Group S.A. MOVE.SW	0.00%	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0.00%	-	CN

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj